Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-02
prorx llc Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-02 recalled by FDA. Lack of Assurance of Sterility
By RecallRadar Editorial Team
Sourced from FDA. Last reviewed March 4, 2026.
This recall involves safety concerns. Take action promptly.
✨ Plain-English Summary
prorx llc Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-02 recalled by FDA. Lack of Assurance of Sterility
Is This Recall Still Active?
Status: Yes - Active
This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.
Source & Verification
This page summarizes the official notice and keeps key facts easy to verify.
- Official source
- FDA
- Announced by source
- October 15, 2025
- Last reviewed by RecallRadar
- March 4, 2026
What You Should Do
- 1## Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA
- 2NDC: 84139-225-02 Agency: FDA | Category: drug Reason: Lack of Assurance of Sterility What to do:
- 3Stop using the product if your lot/model matches.
- 4Check the FDA notice for specifics.
What's Being Recalled
Quoted source excerpt from the official notice.
Lack of Assurance of Sterility
Who's Affected
Specific models and identifiers listed in the source notice:
Model #1
Lot PRORX052125-4
| # | Model |
|---|---|
| 1 | Lot PRORX052125-4 |
Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.
Frequently Asked Questions
Is my prorx llc device affected?
Check the affected models section on this page. The official notice currently lists Lot PRORX052125-4.
What is the remedy for this recall?
## Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-02 Agency: FDA | Category: drug Reason: Lack of Assurance of Sterility What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.
Where can I verify recall details?
Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts
Keep browsing with these internal hubs: prorx llc recall hub and Food & Drug recall hub.
Official Resources
Use these primary sources for final eligibility and claim instructions.
View official notice from FDASee an inaccuracy?
Help us improve the accuracy of this recall information.
Quick Info
- Brand
- prorx llc
- Category
- drug
- Source Agency
- FDA
- Announced
- October 15, 2025
- Country
- US
- Status
- Active
Source & Verification
Sourced from FDA. Last reviewed March 4, 2026.
- Official source
- FDA
- Announced by source
- October 15, 2025
- Last reviewed by RecallRadar
- March 4, 2026
Official Resources
Use these primary sources for final eligibility and claim instructions.
Open Official Recall NoticeView official notice from FDAStay Protected
Register your devices to get notified about future recalls automatically.
View PlansRegister a device →Related Recalls
Compliments Organic brand Dark Chocolate with Sea Salt recalled
Recalls and safety alerts
Mar 2, 2026
Various macadamia nuts and macadamia nut-containing products recalled
Recalls and safety alerts
Mar 2, 2026
Discovery Kitchens brand Beef Cabbage Rolls recalled
Recalls and safety alerts
Mar 2, 2026
Various brands of Curry Powder Madras recalled
Recalls and safety alerts
Feb 28, 2026
Arbutus Foods brand Madras Curry Couscous recalled
Recalls and safety alerts
Feb 28, 2026